Cargando…
Immune checkpoint inhibitors: friend or foe for osteoporosis
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983083/ https://www.ncbi.nlm.nih.gov/pubmed/36876151 http://dx.doi.org/10.1177/20420188231157194 |
_version_ | 1784900469639872512 |
---|---|
author | Tang, Jun |
author_facet | Tang, Jun |
author_sort | Tang, Jun |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9983083 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-99830832023-03-04 Immune checkpoint inhibitors: friend or foe for osteoporosis Tang, Jun Ther Adv Endocrinol Metab Letter to the Editor SAGE Publications 2023-03-01 /pmc/articles/PMC9983083/ /pubmed/36876151 http://dx.doi.org/10.1177/20420188231157194 Text en © The Author(s), 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Letter to the Editor Tang, Jun Immune checkpoint inhibitors: friend or foe for osteoporosis |
title | Immune checkpoint inhibitors: friend or foe for
osteoporosis |
title_full | Immune checkpoint inhibitors: friend or foe for
osteoporosis |
title_fullStr | Immune checkpoint inhibitors: friend or foe for
osteoporosis |
title_full_unstemmed | Immune checkpoint inhibitors: friend or foe for
osteoporosis |
title_short | Immune checkpoint inhibitors: friend or foe for
osteoporosis |
title_sort | immune checkpoint inhibitors: friend or foe for
osteoporosis |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983083/ https://www.ncbi.nlm.nih.gov/pubmed/36876151 http://dx.doi.org/10.1177/20420188231157194 |
work_keys_str_mv | AT tangjun immunecheckpointinhibitorsfriendorfoeforosteoporosis |